On February 27, the Biotechnology Innovation Organization (BIO) premiers its Spring season of the I am BIO podcast with a discussion of new options for sickle cell patients. A groundbreaking treatment using CRISPR technology provides new hope for the nearly 100,000 Americans living with sickle cell disease – a disease and community that has been neglected for decades. “The recent FDA gene-therapy approvals reflect breathtaking progress, not only for sickle cell patients, but also the biotech industry,” said...